- Report
- May 2024
- 185 Pages
Global
From €3999EUR$4,500USD£3,494GBP
- Report
- September 2024
- 82 Pages
Japan
From €3111EUR$3,500USD£2,718GBP
- Report
- September 2024
- 82 Pages
Japan
From €3111EUR$3,500USD£2,718GBP
- Report
- August 2024
- 80 Pages
Japan
From €3111EUR$3,500USD£2,718GBP
- Report
- October 2023
- 190 Pages
Global
From €3999EUR$4,500USD£3,494GBP
- Report
- June 2023
- 112 Pages
Global
From €3999EUR$4,500USD£3,494GBP
- Report
- May 2024
- 139 Pages
Global
From €4909EUR$5,524USD£4,290GBP
€5776EUR$6,499USD£5,047GBP
- Report
- May 2024
- 134 Pages
Global
From €4909EUR$5,524USD£4,290GBP
€5776EUR$6,499USD£5,047GBP
- Report
- May 2022
- 70 Pages
Global
From €2222EUR$2,500USD£1,941GBP
- Report
- July 2024
- 185 Pages
Global
From €2222EUR$2,500USD£1,941GBP
- Report
- May 2024
- 174 Pages
Global
From €2222EUR$2,500USD£1,941GBP
- Report
- October 2021
- 288 Pages
Global
From €3199EUR$3,600USD£2,795GBP
- Report
- November 2024
- 150 Pages
Global
From €3422EUR$3,850USD£2,990GBP
€4310EUR$4,850USD£3,766GBP
- Report
- February 2024
- 140 Pages
Global
From €4416EUR$4,969USD£3,858GBP
- Report
- July 2024
- 200 Pages
Global
From €4398EUR$4,949USD£3,843GBP
- Report
- April 2023
- 147 Pages
Global
From €4398EUR$4,949USD£3,843GBP
- Report
- April 2023
- 147 Pages
Global
From €4398EUR$4,949USD£3,843GBP
- Report
- April 2023
- 147 Pages
Global
From €4398EUR$4,949USD£3,843GBP
- Report
- July 2024
- 200 Pages
Global
From €4398EUR$4,949USD£3,843GBP
- Report
- June 2024
- 200 Pages
Global
From €4439EUR$4,995USD£3,879GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more